<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39407171</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Post‑recovery symptoms of infected cases after Omicron pandemic: a quick online cross-sectional study based on C19-YRSm in China.</ArticleTitle><Pagination><StartPage>2833</StartPage><MedlinePgn>2833</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2833</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-20282-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The post COVID-19 health condition of Chinese residents infected with Omicron is not clear after the change of epidemic prevention policies. This study aimed to clarify the epidemiology and associated factors about health status of rehabilitation patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A quick questionnaire study based on C19-YRSm was conducted in mainland China through internet from May 1, 2023, to May 7, 2023. Chinese native speakers infected with Omicron variant agreed to participate were included. Persisting symptom and living habits were simultaneously inquired. Logistic regression analysis was used to identify the associated factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In this study 753 individuals were included. Of whom 57.90% were males, 89.38% did not seek medical service, 99.47% recovered within less than 120 days. Breathlessness (47.68%), cognitive impairment (44.89%), Anxiety/mood changes (33.20%), pain/discomfort (32.94%), fatigue or tiredness not improved by rest (32.27%) and post-exertional malaise (30.01%) were the top reported key symptoms. Less than 10% respondents reported functional limitations. The prevalence of fever was reported greater than that of other symptoms, with dry eyes at 14.87%, appetite change at 14.34%, and hair loss at 12.22%. Middle age (OR: 2.353, 95%CI: 1.171 ~ 4.729), underlying diseases (OR: 2.293, 95%CI: 1.216 ~ 4.324), severe key symptom (OR: 6.168, 95%CI: 1.376 ~ 27.642) and at least one other symptom (OR: 1.847, 95%CI: 1.225 ~ 2.718)during the recovery were the risk factors of poor overall health after infection (current overall health score &lt;8; 74.10%), while daily exercise in recovery period (OR: 0.457, 95%CI: 0.229 ~ 0.913), a low-fat diet (OR: 0.600, 95%CI: 0.401 ~ 0.898) and the recovery time from 2 to 4 months (OR: 0.639, 95%CI: 0.445 ~ 0.918) were the protective factors.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This is the first time to use the C19-YRSm scale to evaluate the health status in China. The study revealed prevalence of persistent symptoms within 120 days after Omicron onset.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ye</LastName><ForeName>Xiao-Lei</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China. 1016751991@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Xi 'an Jiaotong University in Shaanxi Province, Xi 'an, 710000, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dai</LastName><ForeName>Xin-Hua</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gan</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Ai-Miao</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Li-Zhi</ForeName><Initials>LZ</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Baiyin Central Hospital, Baiyin, 730900, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ai</LastName><ForeName>Le-Le</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Nanjing Bioengineering (Gene)Technology Center for Medicines, Zhongshan East Road, 293, Nanjing, 210002, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yi-Fan</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Stomatology, the 940th Hospital of Joint Logistic Support Force of the Chinese People's Liberation Army, Lanzhou, 730030, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Third People's Hospital of Chengdu (Affiliated Hospital of Southwest Jiaotong University), Chengdu, 610000, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Lanzhou Enci Stomatological Hospital, Lanzhou, 730030, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Qing-Ming</ForeName><Initials>QM</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China. shiqingming1980@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Jun-Feng</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China. zheng-junfeng@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Wei-Long</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Nanjing Bioengineering (Gene)Technology Center for Medicines, Zhongshan East Road, 293, Nanjing, 210002, P. R. China. njcdc@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xiao-Bing</ForeName><Initials>XB</Initials><AffiliationInfo><Affiliation>Center for Disease Control and Prevention in Western Theater Command, Lanzhou, 730030, P. R. China. 18981715872@189.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BE2022682</GrantID><Agency>Social Development Project of Jiangsu Province</Agency><Country /></Grant><Grant><GrantID>BK20221196</GrantID><Agency>Natural Science Foundation of Jiangsu Province</Agency><Country /></Grant><Grant><GrantID>2024YQZL02</GrantID><Agency>Social Development Project</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C19-YRSm</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">Post recovery</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>23</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39407171</ArticleId><ArticleId IdType="pmc">PMC11481264</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-20282-6</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-20282-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>NEHME M, BRAILLARD O, CHAPPUIS F, et al. One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals [J]. J Intern Med. 2022;292(1):103–15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115262</ArticleId><ArticleId IdType="pubmed">35555926</ArticleId></ArticleIdList></Reference><Reference><Citation>NEHME M, VETTER P, CHAPPUIS F, et al. Prevalence of post-COVID Condition 12 weeks after Omicron Infection Compared to Negative Controls and Association with Vaccination Status [J]. Clin Infect Dis; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">36519381</ArticleId></ArticleIdList></Reference><Reference><Citation>NEHME M, BRAILLARD O, CHAPPUIS F, et al. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting [J]. Ann Intern Med. 2021;174(9):1252–60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>BLOMBERG B, MOHN K G, BROKSTAD K A, et al. Long COVID in a prospective cohort of home-isolated patients [J]. Nat Med. 2021;27(9):1607–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>AYOUBKHANI D, KHUNTI K. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study [J]. BMJ. 2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>NAIK H, SHAO S, TRAN K C, et al. Evaluating fatigue in patients recovering from COVID-19: validation of the fatigue severity scale and single item screening questions [J]. Health Qual Life Outcomes. 2022;20(1):170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9792925</ArticleId><ArticleId IdType="pubmed">36575437</ArticleId></ArticleIdList></Reference><Reference><Citation>AL-HUSINAT L, NUSIR M, AL-GHARAIBEH H, et al. Post-COVID-19 syndrome symptoms after mild and moderate SARS-CoV-2 infection [J]. Front Med (Lausanne). 2022;9:1017257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9573938</ArticleId><ArticleId IdType="pubmed">36262270</ArticleId></ArticleIdList></Reference><Reference><Citation>MORIOKA S, TSUZUKI S, SUZUKI M, et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2 [J]. J Infect Chemother. 2022;28(11):1546–51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>GOTTLIEB M, WANG R, YU H, et al. Severe fatigue and persistent symptoms at three months following SARS-CoV-2 infections during the Pre-delta, Delta, and Omicron Time periods: a Multicenter prospective cohort study [J]. Clin Infect Dis; 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10249989</ArticleId><ArticleId IdType="pubmed">36705268</ArticleId></ArticleIdList></Reference><Reference><Citation>YANG X, HOU C, SHEN Y, et al. Two-Year Health outcomes in hospitalized COVID-19 survivors in China [J]. JAMA Netw Open. 2022;5(9):e2231790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9478774</ArticleId><ArticleId IdType="pubmed">36107425</ArticleId></ArticleIdList></Reference><Reference><Citation>HUANG L, YAO Q, GU X, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study [J]. Lancet. 2021;398(10302):747–58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>HUANG C, HUANG L, WANG Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study [J]. Lancet. 2023;401(10393):e21–33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>CAI J, LIN K, ZHANG H, et al. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China [J]. Emerg Microbes Infect. 2023;12(2):2220578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10281439</ArticleId><ArticleId IdType="pubmed">37272336</ArticleId></ArticleIdList></Reference><Reference><Citation>O’BRIEN K, DOWDS TOWNSENDL. 1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study [J]. Respir Res. 2022;23(1):115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9067558</ArticleId><ArticleId IdType="pubmed">35509060</ArticleId></ArticleIdList></Reference><Reference><Citation>FANG X, MING C, CEN Y, et al. Post-sequelae one year after hospital discharge among older COVID-19 patients: a multi-center prospective cohort study [J]. J Infect. 2022;84(2):179–86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662958</ArticleId><ArticleId IdType="pubmed">34902448</ArticleId></ArticleIdList></Reference><Reference><Citation>LIU YH, WANG Y R, WANG Q H, et al. Post-infection cognitive impairments in a cohort of elderly patients with COVID-19 [J]. Mol Neurodegener. 2021;16(1):48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8287105</ArticleId><ArticleId IdType="pubmed">34281568</ArticleId></ArticleIdList></Reference><Reference><Citation>BAUM P, DO L. Cardiac function in relation to functional status and fatigue in patients with post-COVID syndrome [J]. Sci Rep. 2022;12(1):19575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9664421</ArticleId><ArticleId IdType="pubmed">36380000</ArticleId></ArticleIdList></Reference><Reference><Citation>WANG M, LIU Z, WANG Z et al. Clinical characteristics of 1139 mild cases of the SARS-CoV-2 Omicron variant infected patients in Shanghai [J].J Med Virol. 2023;95(1):e28224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9874495</ArticleId><ArticleId IdType="pubmed">36238984</ArticleId></ArticleIdList></Reference><Reference><Citation>WU Q, WANG H, CAI J, et al. Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai [J]. Emerg Microbes Infect. 2023;12(1):e2169197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9888446</ArticleId><ArticleId IdType="pubmed">36644859</ArticleId></ArticleIdList></Reference><Reference><Citation>SIVAN M, PRESTON N, PARKIN A, et al. The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for long covid or Post-COVID-19 syndrome [J]. J Med Virol. 2022;94(9):4253–64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9348420</ArticleId><ArticleId IdType="pubmed">35603810</ArticleId></ArticleIdList></Reference><Reference><Citation>SIVAN M, PARKIN A, MAKOWER S, et al. Post-COVID syndrome symptoms, functional disability, and clinical severity phenotypes in hospitalized and nonhospitalized individuals: a cross-sectional evaluation from a community COVID rehabilitation service [J]. J Med Virol. 2022;94(4):1419–27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661751</ArticleId><ArticleId IdType="pubmed">34783052</ArticleId></ArticleIdList></Reference><Reference><Citation>PARTIPRAJAK S, KRONGTHAEO S, PIASEU N, et al. The Thai version of the COVID-19 Yorkshire Rehabilitation Scale: a valid instrument for the psychometric assessment of the community members in Bangkok, Thailand [J]. BMC Public Health. 2023;23(1):663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10088103</ArticleId><ArticleId IdType="pubmed">37041552</ArticleId></ArticleIdList></Reference><Reference><Citation>DA VITóRIA A G, DE SOUZA COUTO OLIVEIRA J, DE ALMEIDA PEREIRA L C et al. Food safety knowledge, attitudes and practices of food handlers: a cross-sectional study in school kitchens in Espírito Santo, Brazil [J]. BMC Public Health, 2021, 21(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881630</ArticleId><ArticleId IdType="pubmed">33579231</ArticleId></ArticleIdList></Reference><Reference><Citation>GAROUT M A, SALEH S A K, ADLY H M, et al. Post-COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia [J]. Infection. 2022;50(6):1431–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8924350</ArticleId><ArticleId IdType="pubmed">35294728</ArticleId></ArticleIdList></Reference><Reference><Citation>HUANG C, HUANG L, WANG Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study [J]. Lancet. 2021;397(10270):220–32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>RAVAGLIA C, DOGLIONI C, CHILOSI M et al. Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection [J]. Eur Respir J, 2022, 60(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8932282</ArticleId><ArticleId IdType="pubmed">35301248</ArticleId></ArticleIdList></Reference><Reference><Citation>ZHENG B, DAINES L, HAN Q et al. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis [J]. Eur Respir Rev, 2022, 31(166).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724798</ArticleId><ArticleId IdType="pubmed">36323418</ArticleId></ArticleIdList></Reference><Reference><Citation>WU X, LIU X, ZHOU Y, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study [J]. Lancet Respir Med. 2021;9(7):747–54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>MCWHIRTER L, SMYTH H, HOERITZAUER I, et al. What is brain fog? [J]. J Neurol Neurosurg Psychiatry. 2023;94(4):321–5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36600580</ArticleId></ArticleIdList></Reference><Reference><Citation>DENNIS A, CUTHBERTSON D J, WOOTTON D, et al. Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study [J]. J R Soc Med. 2023;116(3):97–112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>COLIZZI M, PEGHIN M, DE MARTINO M, et al. Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors [J]. Rev Psiquiatr Salud Ment; 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212931</ArticleId><ArticleId IdType="pubmed">35755492</ArticleId></ArticleIdList></Reference><Reference><Citation>MARTíNEZ-MáRMOL R, GIORDANO-SANTINI R KAULICHE, et al. SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity [J]. Sci Adv. 2023;9(23):eadg2248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10246911</ArticleId><ArticleId IdType="pubmed">37285437</ArticleId></ArticleIdList></Reference><Reference><Citation>HARRISON PJ. TAQUET M. Neuropsychiatric disorders following SARS-CoV-2 infection [J]. Brain, 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10232232</ArticleId><ArticleId IdType="pubmed">36729559</ArticleId></ArticleIdList></Reference><Reference><Citation>AL-HAKEIM H K, AL-RUBAYE H T, AL-HADRAWI D S, et al. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study [J]. Mol Psychiatry. 2023;28(2):564–78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>CAMPOS MC, NERY T, STARKE A C, et al. Post-viral fatigue in COVID-19: a review of symptom assessment methods, mental, cognitive, and physical impairment [J]. Neurosci Biobehav Rev. 2022;142:104902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9528075</ArticleId><ArticleId IdType="pubmed">36202253</ArticleId></ArticleIdList></Reference><Reference><Citation>MAZZA M G, PALLADINI M, VILLA G, et al. Prevalence, trajectory over time, and risk factor of post-COVID-19 fatigue [J]. J Psychiatr Res. 2022;155:112–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9391361</ArticleId><ArticleId IdType="pubmed">36029623</ArticleId></ArticleIdList></Reference><Reference><Citation>TRAN V T, PORCHER R, PANE I, et al. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort [J]. Nat Commun. 2022;13(1):1812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>SUNADA N, NAKANO Y, OTSUKA Y et al. Characteristics of Sleep Disturbance in patients with long COVID: a retrospective observational study in Japan [J]. J Clin Med, 2022, 11(24).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9783729</ArticleId><ArticleId IdType="pubmed">36555948</ArticleId></ArticleIdList></Reference><Reference><Citation>DE OLIVEIRA ALMEIDA K, NOGUEIRA ALVES I G, DE QUEIROZ R S et al. A systematic review on physical function, activities of daily living and health-related quality of life in COVID-19 survivors [J]. Chronic Illn, 2023;19(2):279-303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9006095</ArticleId><ArticleId IdType="pubmed">35404175</ArticleId></ArticleIdList></Reference><Reference><Citation>MALIK P, PATEL K, PINTO C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis [J]. J Med Virol. 2022;94(1):253–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>PERLIS R H, LUNZ TRUJILLO K, SAFARPOUR A, et al. Association of Post-COVID-19 Condition Symptoms and employment status [J]. JAMA Netw Open. 2023;6(2):e2256152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932847</ArticleId><ArticleId IdType="pubmed">36790806</ArticleId></ArticleIdList></Reference><Reference><Citation>LUO J, ZHANG J, TANG H T, et al. Prevalence and risk factors of long COVID 6–12 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong [J]. J Med Virol. 2023;95(6):e28862.</Citation><ArticleIdList><ArticleId IdType="pubmed">37334978</ArticleId></ArticleIdList></Reference><Reference><Citation>BARAZZONI R, BISCHOFF S C BUSETTOL, et al. Nutritional management of individuals with obesity and COVID-19: ESPEN expert statements and practical guidance [J]. Clin Nutr. 2022;41(12):2869–86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110326</ArticleId><ArticleId IdType="pubmed">34140163</ArticleId></ArticleIdList></Reference><Reference><Citation>OSTROWSKA M, RZEPKA-CHOLASINSKA A, PIETRZYKOWSKI L et al. Effects of Multidisciplinary Rehabilitation Program in patients with long COVID-19: Post-COVID-19 Rehabilitation (PCR SIRIO 8) study [J]. J Clin Med, 2023, 12(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9864838</ArticleId><ArticleId IdType="pubmed">36675349</ArticleId></ArticleIdList></Reference><Reference><Citation>TARTIBIAN B, KHAYAT S M A, MALEKI B H, et al. The effects of Exercise training on recovery of biochemical and hematological outcomes in patients surviving COVID-19: a Randomized Controlled Assessor-Blinded trial [J]. Sports Med Open. 2022;8(1):152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9782268</ArticleId><ArticleId IdType="pubmed">36562867</ArticleId></ArticleIdList></Reference><Reference><Citation>ZHU Z, PAN X. ZHONG F, et al. What can we learn from the Baduanjin rehabilitation as COVID-19 treatment? A narrative review [J]. Nurs Open; 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9880712</ArticleId><ArticleId IdType="pubmed">36575646</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>